Immunization Improvement Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2010 · third_quarter · Medicare/Medicaid
S.1003 Immunization Improvement Act of 2009 HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
Client expense: $1,600,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Medicare/Medicaid
S.1003 Immunization Improvement Act of 2009 HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
Client expense: $1,210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Medicare/Medicaid
S.1003 Immunization Improvement Act of 2009 HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
Client expense: $2,240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Medicare/Medicaid
S.1003 Immunization Improvement Act of 2009 HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
Client expense: $2,600,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Medicare/Medicaid
S.1003 Immunization Improvement Act of 2009 HR. 323 Comprehensive Insurance Coverage of Childhood Immunization Act of 2009
Client expense: $2,100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
Healthcare Reform House Tri-Committee Healthcare Reform Discussion Draft Senate Finance Committee Healthcare Reform Discussion Draft Senate HELP Committee Affordable Health Choices Act Discussion Draft Health Care Reform Cont... Comparative Effectiveness Research Program Initiatives Hospital Acquired Infections Policy In Vitro Diagnostics Regulatory Oversight Vaccine Access/Financing Follow-on Biologics Reporting of Physician Payments Expansion of 340B Drug Pricing Program Medicaid Rebates Drug Safety E-Pedigree and Anti-counterfeiting Safeguarding America's Pharmaceuticals Act of 2009 (Discussion Draft) H.R. 2749: Food Safety Enhancement Act of 2009 H.R. 759: FDA Globalization Act of 2009 S. 882: Drugs and Device Accountability Act of 2009 S. 525: Pharmaceutical Market Access and Drug Safety Act of 2009 Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act For FY 2010 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 1256: Family Smoking Prevention and Tobacco Control Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 Funding for the Food and Drug Administration H.R. 2997: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Stem Cell Research Medicaid Rebates House Tri-Committee Healthcare Reform Discussion Draft Senate Finance Committee Healthcare Reform Discussion Draft Senate HELP Committee Affordable Health Choices Act Discussion Draft Follow-on Biologics H.R. 1427: Promoting Innovation and Access to Life-Saving Medicines Act H.R. 1548: Pathway for Biosimilars Act of 2009 S. 726: Promoting Innovation and Access to Life-Saving Medicine Act FTC Report on Follow-on Biologics Marketplace Senate HELP Committee Biologics Price Competition and Innovation Act Discussion Draft House Tri-Committee Healthcare Reform Discussion Draft Senate HELP Committee Affordable Health Choices Act Discussion Draft Funding for Biomedical Advanced Research & Development Authority (BARDA) Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2346/S.1054: Supplemental Appropriations for FY 2009 In Vitro Diagnostics Regulatory Oversight Healthcare Reform Bills Comparative Effectiveness Program Initiatives Implementation of H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 2502: Comparative Effectiveness Research Act of 2009 H.R. 2824: Doctor-Patient Relationship and Research Protection Act S.1213: Patient-Centered Outcomes Research Act of 2009 House Tri-Committee Healthcare Reform Discussion Draft Senate Finance Committee Healthcare Reform Discussion Draft Senate HELP Committee Affordable Health Choices Act Discussion Draft Funding for National Institutes of Health Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2346/S.1057: Supplemental Appropriations for FY 2009 Funding for Pandemic Influenza Preparedness Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 2346/S.1057: Supplemental Appropriations for FY 2009 Reporting of Physician Payments S. 301: Physician Payments Sunshine Act of 2009 House Tri-Committee Healthcare Reform Discussion Draft Vaccine Access/ Financing Senate HELP Committee Affordable Health Choices Act Discussion Draft House Tri-Committee Healthcare Reform Discussion Draft Senate Finance Committee Healthcare Reform Discussion Draft S.1003: Immunization Improvement Act of 2009 National Vaccine Advisory Committee Draft Recommendations FDA Regulatory Processes for First-Time Filers Expansion of 340B Drug Pricing Program Senate HELP Committee Affordable Health Choices Act Discussion Draft House Tri-Committee Healthcare Reform Discussion Draft
Client expense: $1,800,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)